REFRACTORY ANEMIA AFTER EPOETIN THERAPY IN PATIENTS WITH CHRONIC RENAL FAILURE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SADEGHI S.; FIROUZAN A.; MAZIYAR S.; MAHDAVI M.M.; NIKROUY N.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY Year:2006 | Volume:15 | Issue:4 Page(s): 167-172

Download Full-Text

Persian Verion

View:

1,040

Download:

Cites:

Information Journal Paper

Title

REFRACTORY ANEMIA AFTER EPOETIN THERAPY IN PATIENTS WITH CHRONIC RENAL FAILURE

Author(s)

Keywords

EPOETIN THERAPYQ4

ANEMIAQ3

HEMODIALYSISQ3

CHRONIC RENAL DISEASEQ3

Abstract

Background: ANEMIA is the most frequent complication of chronic renal failure. EPOETIN THERAPY reveals to be an effective therapy; however, development of anti-erythropoietin antibodies has been reported. The present study was conducted to determine the etiology of refractory ANEMIA after EPOETIN THERAPY in patients with chronic renal failure.Methods: All adult patients (530 patients) who had been prescribed regular HEMODIALYSIS and rHUEPO for at least three months were followed in seven HEMODIALYSIS units in Tehran. During a 6- month period, Venofer-Eprex dose and hemoglobin was recorded monthly. Having ruled out hemolytic and iron deficiently state in severe anemic patients, bone marrow examination was ordered.Results: Of 530 patients, 58% were men with median age of 59 years. About %80 of patients had received baseline dose of at least 4000 units Eprex per week, prescribed subcutaneously after HEMODIALYSIS. Approximately, 21% were not anemic, while 19% did suffer from severe ANEMIA (Hb<8). There were statistically significant associations between severity of ANEMIA and age (p<0.001), longer EPOETIN THERAPY (p<0.001), co-treatment with Venofer (p<0.011) and lack of underlying disease (p<0.04). Bone marrow aspiration was performed for 30 patients and the most frequent findings were ANEMIA due to chronic disease, bone marrow dysphasia, and megaloblastic ANEMIA.Conclusion: In case of poor response to EPOETIN THERAPY, discontinuing the drug is strongly recommended. Bone marrow examination is an appropriate tool to find the cause of refractoriness to EPOETIN THERAPY in HEMODIALYSIS patients.

Cites

No record.

References

No record.

Cite

APA: Copy

SADEGHI, S., FIROUZAN, A., MAZIYAR, S., MAHDAVI, M.M., & NIKROUY, N.. (2006). REFRACTORY ANEMIA AFTER EPOETIN THERAPY IN PATIENTS WITH CHRONIC RENAL FAILURE. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY, 15(4), 167-172. SID. https://sid.ir/paper/98618/en

Vancouver: Copy

SADEGHI S., FIROUZAN A., MAZIYAR S., MAHDAVI M.M., NIKROUY N.. REFRACTORY ANEMIA AFTER EPOETIN THERAPY IN PATIENTS WITH CHRONIC RENAL FAILURE. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY[Internet]. 2006;15(4):167-172. Available from: https://sid.ir/paper/98618/en

IEEE: Copy

S. SADEGHI, A. FIROUZAN, S. MAZIYAR, M.M. MAHDAVI, and N. NIKROUY, “REFRACTORY ANEMIA AFTER EPOETIN THERAPY IN PATIENTS WITH CHRONIC RENAL FAILURE,” MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY, vol. 15, no. 4, pp. 167–172, 2006, [Online]. Available: https://sid.ir/paper/98618/en

Related Journal Papers